| Record ID | ia:thrombosisantith0000unse |
| Source | Internet Archive |
| Download MARC XML | https://archive.org/download/thrombosisantith0000unse/thrombosisantith0000unse_marc.xml |
| Download MARC binary | https://www.archive.org/download/thrombosisantith0000unse/thrombosisantith0000unse_meta.mrc |
LEADER: 03075cam 22005534a 4500
001 ocm45375479
003 OCoLC
005 20200416034927.0
008 000107s2000 enka b 001 0 eng
040 $aUKM$beng$cNLM$dGSU$dBAKER$dCGC$dYDXCP$dWQM$dUKM$dVAM$dAAM$dOCLCF$dUBY$dYDX$dOCLCQ$dOCLCO
015 $aGBA0Z7187$2bnb
016 7 $a100964472$2DNLM
019 $a43337767$a77213732$a77515242
020 $a9781853177750
020 $a185317775X
020 $a1841840645
020 $a9781841840642
035 $a(OCoLC)45375479$z(OCoLC)43337767$z(OCoLC)77213732$z(OCoLC)77515242
042 $apcc
050 14 $aRC647.C55$bT47 2000
060 00 $a2000 K-005
060 10 $aQZ 170$bT53169 2000
082 04 $a616.157$221
245 00 $aThrombosis and antithrombotic therapy /$cGilles Lugassy [and others].
260 $aLondon :$bM. Dunitz ;$aMalden, MA :$bDistributed in the U.S. by Blackwell Science,$c℗♭2000.
300 $avi, 270 pages :$billustrations ;$c22 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references and index.
505 0 $aCh. 1. Hemostasis and thrombosis: physiological and pathological aspects -- Ch. 2. Pathogenesis of coronary arterial thrombosis -- Ch. 3. Inherited thrombophilia -- Ch. 4. Acquired hypercoagulable states -- Ch. 5. Laboratory evaluation of prothrombotic risk -- Ch. 6. Low molecular weight heparins: a comparative review of pharmacodynamic, clinical pharmacology -- Ch. 7. Unfractionated heparin, low molecular weight heparins and heparinoid in orthopedic and trauma surgery -- Ch. 8. Efficacy and safety of low molecular weight heparins in the prevention of venous thromboembolism in general surgery -- Ch. 9. Direct, selective inhibitors of coagulation factors -- Ch. 10. The role of antithrombotic agents in ischemic heart disease: platelet inhibitors -- Ch. 11. The role of antithrombotic agents in ischemic heart disease: anticoagulants -- Ch. 12. Treatment and prevention of acute ischemic stroke -- Ch. 13. Peripheral arterial thrombosis -- Ch. 14. Prevention and treatment of venous thrombosis and pulmonary embolism -- Ch. 15. Gestational thrombosis and pregnancy loss: role of antithrombotic therapy -- Ch. 16. Thrombosis and cancer.
650 0 $aThrombosis.
650 0 $aBlood$xCoagulation.
650 12 $aThrombosis$xdrug therapy.
650 12 $aThrombosis$xprevention & control.
650 22 $aHeparin$xpharmacology.
650 22 $aHeparin$xtherapeutic use.
650 22 $aFibrinolytic Agents$xpharmacology.
650 7 $aBlood$xCoagulation.$2fast$0(OCoLC)fst00834568
650 7 $aThrombosis.$2fast$0(OCoLC)fst01150428
700 1 $aLugassy, Gilles.
938 $aBaker & Taylor$bBKTY$c94.95$d94.95$i185317775X$n0006537249$sactive
938 $aYBP Library Services$bYANK$n100191940
029 0 $aNLM$b100964472
029 1 $aAU@$b000022170920
029 1 $aNZ1$b5479402
029 1 $aYDXCP$b1730261
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 70 OTHER HOLDINGS